Alopecia Areata-Like Presentations With Mogamulizumab Therapy
September 2023
in “
JAAD case reports
”
TLDR Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.
Mogamulizumab, used for treating mycosis fungoides and Sézary syndrome, has been linked to alopecia areata-like presentations. A 71-year-old man with Sézary syndrome developed widespread alopecia and follicular dermatitis after treatment with mogamulizumab. Histopathology showed a predominance of CD8+ T-cells, indicating drug-induced alopecia. After discontinuing mogamulizumab, the patient's Sézary syndrome remained in remission, and his rash resolved. This suggests that mogamulizumab-associated alopecia may be a positive prognostic factor, though further studies are needed.